Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial
PaperCitations, authors & open-access status
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 906 citations, 2016 year and hybrid oa status.
906
Citations
2016
Year
hybrid
OA Status